Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugs-Reference-Cited by-同舟云学术

Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugs

Published:2024-02-23 Issue:3 Volume:33 Page:219-228
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Mozaffari Shilan¹^ORCID,Nikfar Shekoufeh²³^ORCID,Abdollahi Mohammad¹^ORCID

Affiliation:

1. Department of Toxicology and Pharmacology, Faculty of Pharmacy, and Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences, Tehran, Iran

2. Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

3. Personalized Medicine Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran

Funder

No funding

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2024.2320703

Reference60 articles.

1. Novel pharmacological therapies for irritable bowel syndrome

2. Emerging drug for diarrhea predominant irritable bowel syndrome

3. Current US Food and Drug Administration-Approved Pharmacologic Therapies for the Treatment of Irritable Bowel Syndrome with Diarrhea

4. Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome

5. Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opposing Effects of Cannabidiol in Patient-derived Neuroendocrine Tumor, Pheochromocytoma/Paraganglioma Primary Cultures;The Journal of Clinical Endocrinology & Metabolism;2024-04-12